Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia

Demand for live trivalent tick fever vaccine containing Babesia bovis, Babesia bigemina and Anaplasma centrale produced by the Department of Primary Industries, Queensland, has increased from less than 10,000 doses in 1988 to 500,000 doses in 2001. This paper describes a series of trials aimed at ov...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Veterinary parasitology 2003-07, Vol.115 (3), p.213-222
Hauptverfasser:	Standfast, Noel F., Bock, Russell E., Wiecek, Magdalena M., deVos, Albertus J., Jorgensen, Wayne K., Kingston, Terry G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anaplasma - growth & development Anaplasma - immunology Anaplasma centrale Anaplasmosis - immunology Anaplasmosis - parasitology Anaplasmosis - prevention & control Animals Antibodies, Protozoan - blood Babesia - growth & development Babesia - immunology Babesia bigemina Babesia bovis Babesiosis - immunology Babesiosis - parasitology Babesiosis - prevention & control Babesiosis - veterinary Cattle Cattle Diseases - immunology Cattle Diseases - parasitology Cattle Diseases - prevention & control Female Fluorescent Antibody Technique, Indirect Live vaccines Male Parasitemia - immunology Parasitemia - parasitology Parasitemia - prevention & control Parasitemia - veterinary Protozoan Vaccines - immunology Protozoan Vaccines - standards Protozoan Vaccines - supply & distribution Queensland Random Allocation Tick fever vaccine Tick-Borne Diseases - immunology Tick-Borne Diseases - parasitology Tick-Borne Diseases - prevention & control Tick-Borne Diseases - veterinary Vaccination - methods Vaccination - veterinary Vaccines, Combined - immunology Vaccines, Combined - standards Vaccines, Combined - supply & distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!